InBody Co.Ltd Market Cap ($424.41 Million)
Market Cap & Net Worth: InBody Co.Ltd (041830)
InBody Co.Ltd market cap. InBody Co.Ltd (KQ:041830) has a market capitalization of $424.41 Million (₩626.27 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #12728 globally and #358 in its home market, demonstrating a 1.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying InBody Co.Ltd's stock price ₩46450.00 by its total outstanding shares 13482600 (13.48 Million). Also see cash flow conversion of InBody Co.Ltd for how efficiently the company converts equity into cash flow.
InBody Co.Ltd Market Cap History (2015–2026)
InBody Co.Ltd market cap history from 2015 to 2026. Data shows growth from $497.69 Million to $424.41 Million (1.92% CAGR). Check InBody Co.Ltd stock quote for real-time trading data and today's change.
Index Memberships
InBody Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.21% | #89 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.21% | #89 of 1384 |
Weight: InBody Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
InBody Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how InBody Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of InBody Co.Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
InBody Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
InBody Co.Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $497.69 Million | $68.95 Billion | $17.31 Billion | 0.01x | 0.03x |
| 2016 | $232.60 Million | $79.85 Billion | $16.99 Billion | 0.00x | 0.01x |
| 2017 | $346.53 Million | $93.25 Billion | $19.32 Billion | 0.00x | 0.02x |
| 2018 | $188.60 Million | $99.64 Billion | $19.67 Billion | 0.00x | 0.01x |
| 2019 | $206.78 Million | $117.06 Billion | $20.43 Billion | 0.00x | 0.01x |
| 2020 | $152.97 Million | $107.12 Billion | $17.52 Billion | 0.00x | 0.01x |
| 2021 | $205.93 Million | $137.84 Billion | $34.03 Billion | 0.00x | 0.01x |
| 2022 | $182.44 Million | $160.00 Billion | $33.82 Billion | 0.00x | 0.01x |
| 2023 | $231.62 Million | $170.35 Billion | $36.72 Billion | 0.00x | 0.01x |
| 2024 | $211.98 Million | $204.46 Billion | $33.14 Billion | 0.00x | 0.01x |
Competitor Companies of 041830 by Market Capitalization
Companies near InBody Co.Ltd in the global market cap rankings as of November 4, 2026. Also see InBody Co.Ltd balance sheet assets for a full breakdown of the balance sheet.
Key companies related to InBody Co.Ltd by market ranking:
- INFINITT Healthcare Co. Ltd (KQ:071200): Ranked #16564 globally with a market cap of $187.66 Million USD ( ₩276.92 Billion KRW).
- Value Added Technology Co. Ltd (KQ:043150): Ranked #17094 globally with a market cap of $164.85 Million USD ( ₩243.26 Billion KRW).
- i-SENS Inc (KQ:099190): Ranked #17118 globally with a market cap of $163.75 Million USD ( ₩241.64 Billion KRW).
- Sewoon Medical Co. Ltd (KQ:100700): Ranked #20601 globally with a market cap of $66.16 Million USD ( ₩97.62 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16564 | INFINITT Healthcare Co. Ltd | KQ:071200 | $187.66 Million | ₩11360.00 |
| #17094 | Value Added Technology Co. Ltd | KQ:043150 | $164.85 Million | ₩16600.00 |
| #17118 | i-SENS Inc | KQ:099190 | $163.75 Million | ₩17590.00 |
| #20601 | Sewoon Medical Co. Ltd | KQ:100700 | $66.16 Million | ₩2255.00 |
Market Capitalization of InBody Co.Ltd (2015–2026)
Market capitalization of InBody Co.Ltd from 2015 to today. Between 2015 and today, InBody Co.Ltd's market cap moved from $497.69 Million to $ 424.41 Million, with a yearly change of 1.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩424.41 Million | +41.83% |
| 2025 | ₩299.24 Million | +41.16% |
| 2024 | ₩211.98 Million | -8.48% |
| 2023 | ₩231.62 Million | +26.96% |
| 2022 | ₩182.44 Million | -11.41% |
| 2021 | ₩205.93 Million | +34.62% |
| 2020 | ₩152.97 Million | -26.02% |
| 2019 | ₩206.78 Million | +9.64% |
| 2018 | ₩188.60 Million | -45.58% |
| 2017 | ₩346.53 Million | +48.98% |
| 2016 | ₩232.60 Million | -53.26% |
| 2015 | ₩497.69 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of InBody Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $424.41 Million USD |
| MoneyControl | $424.41 Million USD |
| MarketWatch | $424.41 Million USD |
| marketcap.company | $424.41 Million USD |
| Reuters | $424.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About InBody Co.Ltd
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was foun… Read more